Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2023-03-03

EMA Authorised: Efavirenz Teva (efavirenz) — Teva B.V.

View source ↗

Summary

EFAVIRZEN Teva has been authorised in the EU for HIV infection treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Efavirenz Teva (efavirenz)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: Teva B.V.. Decision date: 27/02/2023